CDRH Issues Guidance on Brain-computer Interface Devices: https://ift.tt/2SXZkiX #pharma #regulatory

Less than a week left - EDQM Conference Early Bird ends on 28 February: https://ift.tt/2VkwshR #pharma #regulatory

NICE blames BioMarin for Brineura rejection after price talks break down: https://ift.tt/2GD1fD7 #pharma #regulatory

Does Pfizer's Xeljanz share its CV safety questions with burgeoning JAK class?: https://ift.tt/2NkBTKG #pharma #regulatory

Medical Product Alert N° 3/2019 (English version): https://ift.tt/2U2AXx9 #pharma #regulatory

Ciclesonide - Summary opinion of the CVMP on the establishment of maximum residue limits: https://ift.tt/2tzCFdS #pharma #regulatory

Bayer to cut 200 jobs at U.S. logistics center as it alters course for pharma: https://ift.tt/2SfLOSN #pharma #regulatory

Bayer pairs its products in first-ever TV ad for hormone-releasing IUDs: https://ift.tt/2BMkqq4 #pharma #regulatory

AbbVie’s cancer drug Venclexta blocks diabetes in mice by targeting beta cell ‘senescence’ : https://ift.tt/2E4Kjlj #pharma #regulatory

FDA Defends its Efforts to Ensure Generic Drug Quality: https://ift.tt/2GDfiIN #pharma #regulatory